Literature DB >> 30348891

Foxp3 expression in induced regulatory T cells is stabilized by C/EBP in inflammatory environments.

Sungkyu Lee1, Kyungsoo Park1, Jieun Kim1, Hyungyu Min1, Rho H Seong2.   

Abstract

Proper control of immune responses by Foxp3+ regulatory T cells at inflamed sites is crucial for the prevention of immunopathology. TGF-β-induced Foxp3+ regulatory T (Treg) cells are generated in inflammatory environments as well as in steady-state conditions. Inflammatory cytokines such as IFN-γ and IL-4 have an antagonistic effect on Treg cell conversion. However, it is not known how naive CD4+ T cells overcome the inhibitory environment in inflamed sites to differentiate into Treg cells. Here, we show that CCAAT/enhancer-binding protein (C/EBP) functions as a safeguard that enhances Treg cell generation by dampening the inhibitory effect of IFN-γ and IL-4 on Foxp3 expression. We find that C/EBPβ is induced by retinoic acid and binds to the methyl-CRE sequence in the Foxp3 TSDR to sustain its expression. C/EBPβ-transduced iTreg cells show more potent suppressive activity in mouse disease models. We also reveal that C/EBPβ-transduced human iTreg cells exhibit more enhanced suppressor function. These results establish C/EBP as a new molecular target for enhancing the formation and stability of Treg cells in inflammatory environments.
© 2018 The Authors.

Entities:  

Keywords:  C/EBP; Foxp3; iTreg; inflammatory cytokines

Mesh:

Substances:

Year:  2018        PMID: 30348891      PMCID: PMC6280649          DOI: 10.15252/embr.201845995

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  36 in total

1.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.

Authors:  Naganari Ohkura; Masahide Hamaguchi; Hiromasa Morikawa; Kyoko Sugimura; Atsushi Tanaka; Yoshinaga Ito; Motonao Osaki; Yoshiaki Tanaka; Riu Yamashita; Naoko Nakano; Jochen Huehn; Hans Joerg Fehling; Tim Sparwasser; Kenta Nakai; Shimon Sakaguchi
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

Review 2.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

3.  Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation.

Authors:  Maria A Curotto de Lafaille; Nino Kutchukhidze; Shiqian Shen; Yi Ding; Herman Yee; Juan J Lafaille
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

4.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

Review 5.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

Authors:  Jochen Huehn; Julia K Polansky; Alf Hamann
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

6.  Brca2 deficiency leads to T cell loss and immune dysfunction.

Authors:  Jun-Hyeon Jeong; Areum Jo; Pilgu Park; Hyunsook Lee; Hae-Ock Lee
Journal:  Mol Cells       Date:  2015-02-04       Impact factor: 5.034

7.  Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines.

Authors:  Jens Nolting; Carolin Daniel; Sabine Reuter; Christina Stuelten; Peng Li; Henry Sucov; Byung-Gyu Kim; John J Letterio; Karsten Kretschmer; Hye-Jung Kim; Harald von Boehmer
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

8.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

9.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.

Authors:  Cheng-Ming Sun; Jason A Hall; Rebecca B Blank; Nicolas Bouladoux; Mohamed Oukka; J Rodrigo Mora; Yasmine Belkaid
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

10.  CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

Authors:  Hyoung-Pyo Kim; Warren J Leonard
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

View more
  6 in total

1.  MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.

Authors:  Eros Di Giorgio; Liqing Wang; Yan Xiong; Tatiana Akimova; Lanette M Christensen; Rongxiang Han; Arabinda Samanta; Matteo Trevisanut; Tricia R Bhatti; Ulf H Beier; Wayne W Hancock
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

2.  Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis.

Authors:  Mushref Bakri Assas; Scott Levison; Joanne L Pennock
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

3.  Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation.

Authors:  Evelyn Katy Alvarez-Salazar; Arimelek Cortés-Hernández; Saúl Arteaga-Cruz; Josefina Alberú-Gómez; Gloria Soldevila
Journal:  Front Immunol       Date:  2020-04-02       Impact factor: 7.561

4.  Lower Functional and Proportional Characteristics of Cord Blood Treg of Male Newborns Compared with Female Newborns.

Authors:  Viktor Černý; Olga Novotná; Petra Petrásková; Kateřina Hudcová; Kristýna Boráková; Ludmila Prokešová; Libuše Kolářová; Jiří Hrdý
Journal:  Biomedicines       Date:  2021-02-09

5.  Isosteviol Sodium Exerts Anti-Colitic Effects on BALB/c Mice with Dextran Sodium Sulfate-Induced Colitis Through Metabolic Reprogramming and Immune Response Modulation.

Authors:  Shanping Wang; Jiandong Huang; Fei Liu; Keai Sinn Tan; Liangjun Deng; Yue Lin; Wen Tan
Journal:  J Inflamm Res       Date:  2021-12-20

6.  Using high-throughput metabolomics to discover perturbed metabolic pathways and biomarkers of allergic rhinitis as potential targets to reveal the effects and mechanism of geniposide.

Authors:  Yan-Li Zhang; Peng-Cheng Yu; Peng Liu
Journal:  RSC Adv       Date:  2019-06-04       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.